Description
Why It’s Done:
• To identify if Lofloxacin will be effective in treating a patient’s TB infection.
• To detect resistance to Lofloxacin, especially in multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) cases.
• To guide clinicians in tailoring anti-TB therapy for better treatment outcomes.
• To prevent the use of ineffective drugs, reducing the risk of treatment failure and further resistance development.
Preparation:
• No special preparation is required for the patient.
• The patient’s clinical specimen (e.g., sputum, tissue, or body fluid) must be collected in a sterile container and transported promptly to the laboratory.
• Inform the healthcare provider of any current TB or antibiotic treatments, as these might influence the test.
• Because the test depends on bacterial culture, results typically take several weeks
